Home Company Technology Offerings Contact Publications

COMPANY

Company overview

Teicos Pharma Oy aims to become the leading provider of manufacturing solutions for carrier-free inhalable API powders used in dry powder inhalers. We strive to be the preferred partner of pharmaceutical companies acting in the field of inhalation therapy.

Our strategy is to develop, licence and sell customer specific dry powder formulations and reformulations of drug molecules for use in local or systemicinhalation therapy.

 

History

Established in 2007, Teicos Pharma is a spin-off from the Helsinki University of Technology (now Aalto University), Finland. Founding partners include four leading senior scientists from materials, characterization and aerosol technologies originating from Finland and the USA.

 

Partnership

Keksintösäätiö Aalto University

Partners

Teicos Pharma Ltd
Heinasuontie 29
00430 Helsinki
Finland

Home Company Technology Offerings Contact Publications